January 4, 2017—The Department of Health and Human Services published a 340B program final rule today implementing fines for drug manufacturers that knowingly and intentionally overcharge safety-net healthcare providers. The rule also sets standards for calculating 340B ceiling prices.
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)